Holger Hebart, MD; Peter Lang, MD; Wilhelm Woessmann, MD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L16-0037.
Hebart H, Lang P, Woessmann W. Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report. Ann Intern Med. 2016;165:607–608. doi: https://doi.org/10.7326/L16-0037
Download citation file:
Published: Ann Intern Med. 2016;165(8):607-608.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use